ArticleVeterinary medicine and science2025
Development of an In-House Antigen ELISA Using Monoclonal and Polyclonal Antibodies Against an Isolated Canine Distemper Virus.
Article in Veterinary medicine and science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development and Validation of an In-House Indirect ELISA for Serological Detection ofVeterinary medicine international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Canine distemper virus (CDV) is a highly contagious pathogen that affects several animal families. While animals of all ages are susceptible, puppies face the highest risk. This study aimed to detect CDV in dogs with suspected infection, isolate the virus and develop a sensitive antigen-ELISA test using monoclonal and polyclonal antibodies. Samples were collected from 40 dogs and tested by RT-PCR, then cultured positive samples in MDCK cells for virus isolation. In addition, the CDV F protein gene sequence obtained from the MDCK-34388 isolate was added to GenBank. Phylogenetic analysis revealed that the isolate belongs to the Asia-1 genotype. Among the 40 tested dogs, 29 (72.5%) tested positive for CDV, exhibiting respiratory, neurological and mixed symptoms in 62.5%, 15% and 22.5% of cases, respectively. Using an inactivated CDV isolate, we produced monoclonal antibodies in BALB/c mice and polyclonal antibodies in New Zealand rabbits. For ELISA development, we HRP-labelled the 1G10-1A monoclonal antibody that targets the CDV F protein. The antigen ELISA test we developed showed 90% sensitivity and 87.5% specificity, with positive and negative predictive values of 87.8% and 89.74%, respectively. These findings indicate that the antigen ELISA test is a reliable diagnostic tool for CDV detection, complementing RT-PCR and supporting effective disease management for veterinary practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.